| 2023 |
Robert J. Binder, Ph.D. (AAI ’02)
Univ. of Pittsburgh |
Key pathways in immunosurveillance of cancer |
Binder |
| 2022 |
Cherié L. Butts, Ph.D.
Biogen |
Concept to approved drug: why immunologists are critical when developing new medicines |
Butts |
| 2020 |
De’Broski R. Herbert, Ph.D.
Univ. of Pennsylvania Sch. of Vet. Med. |
IL-33 regulates the balance between inflammation and immunosuppression |
Herbert |
| 2019 |
Margaret S. Bynoe, Ph.D.
Cornell University College of Veterinary Medicine |
Adenosine receptor axis in blood brain barrier (BBB) permeability regulation |
Bynoe |
| 2018 |
Elina Zúñiga, Ph.D.
University of California, San Diego |
The art of coexistence: immune adaptations during chronic viral infections |
Zúñiga |
| 2017 |
Tyler J. Curiel, M.D., M.P.H.
The University of Texas Health Science Center at San Antonio |
Advancing towards optimized cancer immunotherapy |
Curiel |
| 2016 |
Prosper N. Boyaka, Ph.D.
Ohio State University |
Diversity: Lessons from regulation of mucosal immunity by toxins and microbiota |
Boyaka |
| 2015 |
Gabriel Núñez, M.D.
University of Michigan |
Linking pathogen virulence, immunity, and the microbiota |
Núñez |
| 2014 |
Arturo Casadevall, Ph.D.
Albert Einstein College of Medicine, Yeshiva University |
A new synthesis for antibody-mediated immunity |
Casadevall |
| 2013 |
Esteban Celis, Ph.D.
Moffitt Cancer Center, University of South Florida |
The long road to effective peptide vaccines for cancer: learning from infectious diseases and autoimmunity |
Celis |
| 2012 |
Charles E. Egwuagu, M.P.H., Ph.D.
National Eye Institute, National Institutes of Health |
Regulation of autoreactive lymphocytes that mediate CNS autoimmune diseases |
Egwuagu |
| 2011 |
Olivia M. Martinez, Ph.D.
Stanford School of Medicine |
Effects of viral proteins on lymphocyte function in Epstein Barr Virus B cell lymphomas |
Martinez |
| 2010 |
Albert Zlotnik, Ph.D.
University of California, Irvine |
An evolutionary view of chemokines |
Zlotnik |
| 2009 |
Emil R. Unanue, M.D.
Washington University School of Medicine |
The mysteries of peptide selection by the class II MHC molecules |
Unanue |
| 2008 |
Juan J. Lafaille, Ph.D.
New York University School of Medicine |
Antigen-induced Foxp3+ regulatory T cells |
Lafaille |
| 2007 |
Avery August, Ph.D.
Pennsylvania State University |
Tec tyrosine kinase modulation of airway responses |
August |
| 2006 |
Diana M. Lopez, Ph.D.
University of Miami |
A unique mucin immunoenhancing peptide with anti-tumor properties |
Lopez |
| 2005 |
Juan Carlos Zúñiga-Pflücker, Ph.D.
Sunnybrook and Women’s Research Institute, University of Toronto |
Becoming a T cell: lineage options and decisions by stem cells |
Zúñiga-Pflücker |
| 2004 |
Randy R. Brutkiewicz, Ph.D.
Indiana University School of Medicine |
CD1d-mediated antigen presentation to NKT Cells |
Brutkiewicz |
| 2003 |
Richard A. Goldsby, Ph.D.
Amherst College |
Human antibody from human artificial chromosome transgenic cloned cattle |
Goldsby |